Elevance Health Shares Trimmed by Iridian Asset Management

Institutional investor reduces stake in major health insurance provider

Apr. 13, 2026 at 10:04am

Got story updates? Submit your updates here. ›

A high-contrast, close-up black and white photograph of the intricate gears, levers, and mechanisms of heavy industrial financial equipment, conveying a sense of the complex infrastructure underlying the health insurance market.This stark, industrial image of the inner workings of the financial system reflects the complex institutional forces shaping the health insurance industry.Indianapolis Today

Iridian Asset Management LLC CT trimmed its position in Elevance Health, Inc. (NYSE:ELV) by 51.9% in the fourth quarter, according to a recent SEC filing. The firm now owns 25,074 shares of the company's stock, down from 52,103 shares previously.

Why it matters

As a major institutional investor, Iridian's reduction in its Elevance Health holdings could signal broader market sentiment or concerns about the health insurance provider's performance and outlook.

The details

Iridian Asset Management reduced its stake in Elevance Health, the rebranded former Anthem, Inc., by over 50% in the fourth quarter of 2025. The firm now holds 25,074 shares of the company's stock, down from 52,103 shares previously. Elevance Health makes up about 3.2% of Iridian's portfolio, making it the 11th largest holding.

  • Iridian Asset Management filed its 13F report with the SEC on April 13, 2026, disclosing the reduced Elevance Health position.
  • The firm trimmed its Elevance Health stake during the fourth quarter of 2025.

The players

Iridian Asset Management LLC CT

An institutional investment management firm that has reduced its position in Elevance Health, Inc.

Elevance Health, Inc.

A major U.S. health benefits company that provides a range of insurance products and services, including medical and specialty health plans.

Got photos? Submit your photos here. ›

The takeaway

Iridian's reduced stake in Elevance Health could signal broader market concerns about the health insurance provider's performance and outlook, though the specific reasons behind the move are not clear from the available information.